{{Drugbox
| Watchedfields = changed
| verifiedrevid = 477869605
| IUPAC_name = (''S'')-4-({3-[2-(dimethylamino)ethyl]-1''H''-indol-5-yl}methyl)-1,3-oxazolidin-2-one
| image = Zolmitriptan Structure V.1.svg
| width = 250
| image2 =  
| width2 = 120

<!--Clinical data-->
| tradename = Zomig
| Drugs.com = {{drugs.com|monograph|zolmitriptan}}
| pregnancy_AU = B3
| pregnancy_US = C
| legal_US = Rx-only
| routes_of_administration = Oral, nasal spray

<!--Pharmacokinetic data-->
| bioavailability = 40% (oral)
| protein_bound = 25%
| metabolism = [[Liver|Hepatic]] ([[CYP1A2|CYP1A2]]-mediated, to active metabolite)
| elimination_half-life = 3 hours
| excretion = [[Kidney|Renal]] (65%) and fecal (35%)

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 139264-17-8
| ATC_prefix = N02
| ATC_suffix = CC03
| ATC_supplemental =  
| PubChem = 60857
| IUPHAR_ligand = 60
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00315
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54844
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2FS66TH3YW
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00415
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 10124
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1185

<!--Chemical data-->
| C=16 | H=21 | N=3 | O=2 
| molecular_weight = 287.357 g/mol
| smiles = O=C1OC[C@@H](N1)Cc2ccc3c(c2)c(cn3)CCN(C)C
| InChI = 1/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
| InChIKey = ULSDMUVEXKOYBU-ZDUSSCGKBB
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ULSDMUVEXKOYBU-ZDUSSCGKSA-N
}}
'''佐米曲普坦''' （{{lang-en|Zolmitriptan}}）是一种选择性[[血清素受体激动剂|5-HT1激动剂]]，通过激动颅内血管（包括动静脉吻合处）和三叉神经系统交感神经上的5-HT1B/1D受体，引起颅内血管收缩并抑制前炎症神经肽的释放，从而作为一种治疗[[偏头痛|偏头痛]]和[[丛集性头痛|丛集性头痛]]的[[曲坦|曲坦]]类药物。

== 说明 ==
佐米曲普坦是一种人工合成的[[色胺|色胺]]衍生物，白色粉末，易溶于水。

== 参考文献 ==
<references/>

*{{cite journal
|journal = Drugs Today
|year = 1998
|volume = 34
|issue =12
|pages = 1027–1033
|doi= 10.1358/dot.1998.34.12.487488	
|title =Zolmitriptan clinical studies
|author =MacGregor, E.A.
|pmid = 14743270}}

== 外部链接 ==
*[http://www.zomig.com Zomig Information Site (USA)]

{{抗偏头痛药}}
{{Serotonergics}}
{{阿斯利康制药}}

[[Category:氨基甲酸酯|Category:氨基甲酸酯]]
[[Category:阿斯利康制药|Category:阿斯利康制药]]